Search clinical trials for: Parathyroid Hormone-related Protein
Total 1461 results
-
National University Hospital, SingaporeEisai Co., Ltd.Recruiting
-
Sun Yat-sen UniversityRecruiting
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Locally Advanced Breast CancerUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
Relay Therapeutics, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Unresectable Solid Tumor | PIK3CA MutationUnited States, Spain, France, Italy
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)WithdrawnGastrointestinal Carcinoid Tumor | Islet Cell Carcinoma
-
University of MessinaMinistry of Education, Universities and Research, ItalyCompleted
-
Duke UniversityBristol-Myers SquibbTerminatedProstate CancerUnited States
-
Danish Headache CenterCompleted
-
GlaxoSmithKlineCompleted
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnProstate CancerUnited States
-
Calliditas Therapeutics ABCompletedPrimary IgA NephropathyUnited States, Australia, Taiwan, Spain, Canada, Argentina, Belarus, Belgium, Czechia, Finland, France, Germany, Greece, Italy, Korea, Republic of, Poland, Sweden, Turkey, United Kingdom
-
University of ChicagoActive, not recruitingBreast Cancer | Triple Negative Breast NeoplasmsUnited States
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingHepatocellular Carcinoma Non-resectableChina
-
Bristol-Myers SquibbTerminatedMultiple MyelomaUnited States, Italy, France, Spain
-
PfizerTerminatedProstatic NeoplasmsUnited States, Canada, Spain, Belgium, Finland, Italy, Korea, Republic of, Poland, Portugal, Slovakia, Sweden, Denmark, Taiwan, China, Australia, Germany, Israel, United Kingdom, Brazil, France, Czech Republic, Peru
-
Fondazione EMN Italy OnlusTerminated
-
Calliditas Therapeutics ABCompletedPrimary IgA NephropathyBelgium, United Kingdom, Denmark, Finland, Sweden, Germany, Spain, Italy, Czech Republic, Netherlands
-
Columbia UniversityAlliance for Better Bone HealthCompletedOsteoporosisUnited States
-
University of CataniaRecruiting
-
Li HuipingNot yet recruiting
-
Dartmouth-Hitchcock Medical CenterRecruitingAdvanced Breast CancerUnited States
-
Hoffmann-La RocheTerminatedBreast CancerUnited States, Brazil, Australia, Canada, Japan, Korea, Republic of, Spain, United Kingdom
-
Beth Israel Medical CenterBayerTerminatedProstate CancerUnited States
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
AbbVieActive, not recruitingTakayasu Arteritis (TAK)Argentina, Brazil, China, Japan, Korea, Republic of, Turkey
-
Memorial Sloan Kettering Cancer CenterNovartis Pharmaceuticals; Incyte CorporationActive, not recruiting
-
Sun Yat-sen UniversityCompletedHepatocellular Carcinoma | Face CancerChina
-
Danish Headache CenterCompletedMigraine Without Aura
-
University of MessinaMinistry of Education, Universities and Research, ItalyCompleted
-
Fudan UniversityRecruitingAdvanced Breast Cancer | HR+/HER2- Breast CancerChina
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Icahn School of Medicine at Mount SinaiNYU Langone Health; Weill Medical College of Cornell University; Herbert Irving...Active, not recruitingAnastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastBreast Neoplasms | Breast DiseasesUnited States
-
MedSIRCompletedMetastatic Breast CancerSpain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
-
NSABP Foundation IncPfizer; Genomic Health®, Inc.CompletedBreast CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
Fondazione Sandro PitiglianiCompleted
-
Consorzio OncotechUnknown
-
AGO Study GroupCompletedOvarian Cancer | Peritoneal Cancer | Cancer of the Fallopian TubeGermany
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Istituti Clinici Scientifici Maugeri SpACompletedFemale | Neoplasm Malignant | BreastItaly
-
Fondazione MichelangeloCompleted
-
Mayo ClinicNational Cancer Institute (NCI)Terminated
-
GlaxoSmithKlinePPDCompletedDiabetes Mellitus, Type 2Spain, Germany, Hungary, Italy, Philippines, France, United States, Mexico, Brazil, South Africa, Korea, Republic of, Canada, Poland, United Kingdom
-
GlaxoSmithKlineCompleted
-
University Hospital, AkerUnknownProstatic NeoplasmsNorway
-
Fundación para la Investigación del Hospital Clínico...University of ValenciaCompleted
-
Imperial College LondonCompletedCoronary Artery DiseaseUnited Kingdom